Drug profile · INN
eprosartan mesylate
TEVETEN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
eprosartan mesylate (TEVETEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN eprosartan mesylate
Brand TEVETEN
Route ORAL
Formulation TABLET
Frequently asked questions
What is eprosartan mesylate?
eprosartan mesylate (TEVETEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eprosartan mesylate?
TEVETEN is a marketed brand name for eprosartan mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eprosartan mesylate?
eprosartan mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.